Trexquant Investment LP

Position in VIR — Vir Biotechnology, Inc.

CIK 1633445 STAMFORD, CT

Position in VIR

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$849,112

-$246,357 QoQ

Shares Held

94,767

-56.4% QoQ

Ownership

0.056%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2020

10 quarters on record

Voting authority Sole 91% Shared 0% None 9%

Healthcare · as of Mar 31, 2026

Trexquant Investment LP holds $496,284,956 across 119 Biotechnology names. VIR ranks #89 (0.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	MRNA	Moderna, Inc.	483,971	$24,585,726
2	ALNY	Alnylam Pharmaceuticals, Inc.	61,760	$20,434,531
3	ARWR	Arrowhead Pharmaceuticals, Inc.	277,114	$17,375,047
4	EXEL	Exelixis, Inc.	390,818	$16,762,184
5	HRMY	Harmony Biosciences Holdings, Inc.	594,850	$16,661,748
6	IONS	Ionis Pharmaceuticals Inc	213,645	$16,042,603
7	CNTA	Centessa Pharmaceuticals plc	390,951	$15,528,573
8	ASND	Ascendis Pharma A/S	65,517	$14,985,703

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$849,112	94,767	-56.4%	Shares	Sole	2026-05-15
2025-06-30	$1,095,469	217,355	+10.3%	Shares	Sole	2025-08-12
2024-09-30	$1,475,462	196,991	+92.6%	Shares	Sole	2024-11-12
2024-06-30	$910,496	102,303	+156.5%	Shares	Sole	2024-08-13
2022-12-31	$1,009,489	39,885	-62.7%	Shares	Sole	2023-02-13
2022-09-30	$2,059,104	106,800	+175.7%	Shares	Sole	2022-11-14
2022-06-30	$986,707	38,740	+154.4%	Shares	Sole	2022-08-11
2022-03-31	$391,612	15,226	-18.5%	Shares	Sole	2022-05-13
2020-12-31	$500,196	18,678	+37.6%	Shares	Sole	2021-02-11
2020-09-30	$466,029	13,575	—	Shares	Sole	2020-11-06
No filing history on record for this holder in this stock.